Hikma Pharmaceuticals PLC - Company Profile and SWOT Analysis
SummaryHikma Pharmaceuticals PLC - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Hikma Pharmaceuticals PLC (Hikma or 'the company') is a manufacturer, developer and marketer of generic and in-licensed pharmaceutical products. The company offers diversified product portfolio and pipeline across a broad range of therapeutic categories including anti-infectives, cardiovascular, central nervous system, diabetes, oncology, pain management and respiratory. It offers its products in various forms such as injectable, oral and other non-injectable generic products. Its major customers in the US and Europe include pharmacy chains, wholesalers, governments, and hospital purchasing organizations. Hikmay primarily operates in the North America, Middle East and North Africa and Europe. The company is headquartered in London, the UK.
Scope
Hikma Pharmaceuticals PLC - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Hikma Pharmaceuticals PLC (Hikma or 'the company') is a manufacturer, developer and marketer of generic and in-licensed pharmaceutical products. The company offers diversified product portfolio and pipeline across a broad range of therapeutic categories including anti-infectives, cardiovascular, central nervous system, diabetes, oncology, pain management and respiratory. It offers its products in various forms such as injectable, oral and other non-injectable generic products. Its major customers in the US and Europe include pharmacy chains, wholesalers, governments, and hospital purchasing organizations. Hikmay primarily operates in the North America, Middle East and North Africa and Europe. The company is headquartered in London, the UK.
Reasons To Buy
- Detailed information on Hikma Pharmaceuticals PLC required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Hikma Pharmaceuticals PLC in the form of a SWOT analysis
- An in-depth view of the business model of Hikma Pharmaceuticals PLC including a breakdown and examination of key business segments
- Intelligence on Hikma Pharmaceuticals PLC's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Hikma Pharmaceuticals PLC, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
MarketLine, a world-leading provider of commercial intelligence, has over 400 experienced analysts, consultants, and researchers with regional and sector expertise in market sizing, competitor tracking, socio and macro economics, and business drivers.
For more than 15 years MarketLine has supported the research needs of investment banks, corporations, professional services firms, and academia with a unique mix of company, industry, country, city and financial data for every major industry and marketplace.
MarketLine’ holistic business intelligence report collection includes:
Industry Intelligence
‒ Industry Profiles
‒ Market Forecasts
‒ Porter’s Five Forces Analysis
Company Intelligence
‒ Company Profiles
‒ SWOT Analysis
‒ Financial Deals
Country and City Intelligence
‒ Country and City Profiles
‒ PEST/PESTLE Analysis
‒ Socio and macro-economic indicators
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.